Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire

Journal of Virology

Volumn 82, Issue 22, 2008, Pages 10986-10997

  Tan, Anthony Oto ^a,b   Loggi, Elisabetta ^c   Boni, Carolina ^d   Chia, Adeline ^a   Gehring, Adam J ^a   Sastry, Konduru S R ^a   Goh, Vera ^a   Fisicaro, Paola ^d   Andreone, Pietro ^c   Brander, Christian ^e,f,g   Seng, Gee Lim ^b   Ferrari, Carlo ^d   Bihl, Florian ^e,h   Bertoletti, Antonio ^a,b,i  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^h GENEVA UNIVERSITY HOSPITALS   (Switzerland)

ⁱ AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA A11 ANTIGEN; VIRUS DNA; EPITOPE;

AMINO ACID SEQUENCE; ARTICLE; CAUCASIAN; CD8+ T LYMPHOCYTE; CHINESE; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION; ASIAN; BIOSYNTHESIS; CLASSIFICATION; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

HEPATITIS B VIRUS;

ASIAN CONTINENTAL ANCESTRY GROUP; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FLOW CYTOMETRY; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON TYPE II; T-LYMPHOCYTE SUBSETS;

EID: 55549116694     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01124-08     Document Type: Article

References (47)

1. Addo, M. M., X. G. Yu, A. Rathod, D. Cohen, R. L. Eldridge, D. Strick, M. N. Johnston, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, M. E. Feeney, W. R. Rodriguez, N. Basgoz, R. Draenert, D. R. Stone, C. Brander, P. J. R. Goulder, E. S. Rosenberg, M. Altfeld, and B. D. Walker. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77:2081-2092.
2. Barouch, D., T. Friede, S. Stevanovic, L. Tussey, K. Smith, S. Rowland-Jones, V. Braud, A. McMichael, and H. G. Rammensee. 1995. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 182:1847-1856.
3. Bertoletti, A., A. Costanzo, F. V. Chisari, M. Levrero, M. Artini, A. Sette, A. Penna, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180:933-943.
4. Bertoletti, A., C. Ferrari, F. Fiaccadori, A. Penna, R. Margolskee, H. Schlicht, P. Fowler, S. Guilhot, and F. Chisari. 1991. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid. Proc. Natl. Acad. Sci. USA 88:10445- 10449.
5. Bertoletti, A., and A. J. Gehring. 2006. The immune response during hepatitis B virus infection. J. Gen. Virol. 87:1439-1449.
6. Bertoni, R., J. Sidney, P. Fowler, R. Chesnut, F. Chisari, and A. Sette. 1997. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Investig. 100:503-513.
7. Boni, C., P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, A. Bertoletti, and C. Ferrari. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81:4215-4225.
8. Brander, C., N. Frahm, and B. D. Walker. 2006. The challenges of host and viral diversity in HIV vaccine design. Curr. Opin. Immunol. 18:430-437.
9. + T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J. Virol. 79:3038-3051.
10. Chen, L., Z. Zhang, W. Chen, Z. Zhang, Y. Li, M. Shi, J. Zhang, L. Chen, S. Wang, and F. S. Wang. 2007. B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J. Immunol. 178:6634-6641.
11. de Campos-Lima, P. O., R. Gavioli, Q. J. Zhang, L. E. Wallace, R. Dolcetti, M. Rowe, A. B. Rickinson, and M. G. Masucci. 1993. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 260:98-100.
12. Depla, E., A. Van der Aa, B. D. Livingston, C. Crimi, K. Allosery, V. De Brabandere, J. Krakover, S. Murthy, M. Huang, S. Power, L. Babé, C. Dahlberg, D. McKinney, A. Sette, S. Southwood, R. Philip, M. J. Newman, and L. Meheus. 2008. Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections. J. Virol. 82:435-450.
13. Frahm, N., B. T. Korber, C. M. Adams, J. J. Szinger, R. Draenert, M. M. Addo, M. E. Feeney, K. Yusim, K. Sango, N. V. Brown, D. SenGupta, A. Piechocka-Trocha, T. Simonis, F. M. Marincola, A. G. Wurcel, D. R. Stone, C. J. Russell, P. Adolf, D. Cohen, T. Roach, A. StJohn, A. Khatri, K. Davis, J. Mullins, P. J. R. Goulder, B. D. Walker, and C. Brander. 2004. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J. Virol. 78:2187-2200.
14. Frahm, N., K. Yusim, T. J. Suscovich, S. Adams, J. Sidney, P. Hraber, H. S. Hewitt, C. H. Linde, D. G. Kavanagh, T. Woodberry, L. M. Henry, K. Faircloth, J. Listgarten, C. Kadie, N. Jojic, K. Sango, N. V. Brown, E. Pae, M. T. Zaman, F. Bihl, A. Khatri, M. John, S. Mallal, F. M. Marincola, B. D. Walker, A. Sette, D. Heckerman, B. T. Korber, and C. Brander. 2007. Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur. J. Immunol. 37:2419-2433.
15. Fung, S. K., and A. S. Lok. 2004. Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40:790-792.
16. Gaudieri, S., A. Rauch, L. P. Park, E. Freitas, S. Herrmann, G. Jeffrey, W. Cheng, K. Pfafferott, K. Naidoo, R. Chapman, M. Battegay, R. Weber, A. Telenti, H. Furrer, I. James, M. Lucas, and S. A. Mallal. 2006. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J. Virol. 80:11094-11104.
17. Gehring, A. J., D. Sun, P. T. Kennedy, E. Nolte-'t Hoen, S. G. Lim, S. Wasser, C. Selden, M. K. Maini, D. M. Davis, M. Nassal, and A. Bertoletti. 2007. The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J. Virol. 81:2940-2949.
18. Hesse, M. D., A. Y. Karulin, B. O. Boehm, P. V. Lehmann, and M. Tary-Lehmann. 2001. A T cell clone's avidity is a function of its activation state. J. Immunol. 167:1353-1361.
19. Hwang, Y. K., N. K. Kim, J. M. Park, K. Lee, W. K. Han, H. I. Kim, and H. S. Cheong. 2002. HLA-A2.1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo. Vaccine 20:3770-3777.
20. Jung, M., B. Hartmann, J. Gerlach, H. Diepolder, R. Gruber, W. Schraut, N. Gruner, R. Zachoval, R. Hoffmann, T. Santantonio, and G. Pape. 1999. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. Virology 261:165-172.
21. Kidd-Ljunggren, K., Y. Miyakawa, and A. H. Kidd. 2002. Genetic variability in hepatitis B viruses. J. Gen. Virol. 83:1267-1280.
22. Krausa, P., and M. J. Browning. 1996. HLA-A2 polymorphism and immune functions. Eur. J. Immunogenet. 23:261-274.
23. Le Gall, S., P. Stamegna, and B. D. Walker. 2007. Portable flanking sequences modulate CTL epitope processing. J. Clin. Investig. 117:3563-3575.
24. Leslie, A., D. A. Price, P. Mkhize, K. Bishop, A. Rathod, C. Day, H. Crawford, I. Honeyborne, T. E. Asher, G. Luzzi, A. Edwards, C. M. Rousseau, J. I. Mullins, G. Tudor-Williams, V. Novelli, C. Brander, D. C. Douek, P. Kiepiela, B. D. Walker, and P. J. Goulder. 2006. Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. J. Immunol. 177:4699-4708.
25. Lindh, M., J. E. Gonzalez, G. Norkrans, and P. Horal. 1998. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J. Virol. Methods 72:163-174.
26. Maini, M. K., C. Boni, G. S. Ogg, A. S. King, S. Reignat, C. K. Lee, J. R. Larrubia, G. J. M. Webster, A. J. McMichael, C. Ferrari, R. Williams, D. Vergani, and A. Bertoletti. 1999. Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection. Gastroenterology 117:1386-1396.
27. Merican, I., R. Guan, D. Amarapuka, M. J. Alexander, A. Chutaputti, R. N. Chien, S. S. Hasnian, N. Leung, L. Lesmana, P. H. Phiet, H. M. Sjalfoellah Noer, J. Sollano, H. S. Sun, and D. Z. Xu. 2000. Chronic hepatitis B virus infection in Asian countries. J. Gastroenterol. Hepatol. 15:1356-1361.
28. Middleton, D., L. Menchaca, H. Rood, and R. Komerofsky. 2003. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61:403-407.
29. Moore, C. B., M. John, I. R. James, F. T. Christiansen, C. S. Witt, and S. A. Mallal. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-1443.
30. Nayersina, R., P. Fowler, S. Guilhot, G. Missale, A. Cerny, H. J. Schlicht, A. Vitiello, R. Chesnut, J. L. Person, A. J. Redeker, and F. V. Chisari. 1993. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659-4671.
31. Penna, A., F. V. Chisari, A. Bertoletti, G. Missale, P. Fowler, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1991. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174:1565-1570.
32. Rehermann, B., P. Fowler, J. Sidney, J. Person, A. Redeker, M. Brown, B. Moss, A. Sette, and F. V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
33. Riedl, P., A. Bertoletti, R. Lopes, F. Lemonnier, J. Reimann, and R. Schirmbeck. 2006. Distinct, cross-reactive epitope specificities of CD8 T cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypes. J. Immunol. 176:4003-4011.
34. Seifert, U., H. Liermann, V. Racanelli, A. Halenius, M. Wiese, H. Wedemeyer, T. Ruppert, K. Rispeter, P. Henklein, A. Sijts, H. Hengel, P. M. Kloetzel, and B. Rehermann. 2004. Hepatitis C virus mutation affects proteasomal epitope processing. J. Clin. Investig. 114:250-259.
35. Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201-212.
36. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586-5592.
37. Sidney, J., B. Peters, N. Frahm, C. Brander, and A. Sette. 2008. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9:1.
38. Sobao, Y., K. Sugi, H. Tomiyama, S. Saito, S. Fujiyama, M. Morimoto, S. Hasuike, H. Tsubouchi, K. Tanaka, and M. Takiguch. 2001. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia. J. Hepatol. 34:922-929.
39. Stevens, C., R. Beasley, and J. Tsu. 1975. Vertical transmission of hepatitis B antigen in Taiwan. N. Engl. J. Med. 292:771-774.
40. Sudo, T., N. Kamikawaji, A. Kimura, Y. Date, C. J. Savoie, H. Nakashima, E. Furuichi, S. Kuhara, and T. Sasazuki. 1995. Differences in MHC class I self peptide repertoires among HLA-A2 subtypes. J. Immunol. 155:4749-4756.
41. Sugimoto, K., J. Stadanlick, F. Ikeda, C. Brensinger, E. E. Furth, H. J. Alter, and K. M. Chang. 2003. Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response. Hepatology 37:590-599.
42. Thimme, R., K.-M. Chang, J. Pemberton, A. Sette, and F. V. Chisari. 2001. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLAB51. J. Virol. 75:3984-3987.
43. Tsai, S. L., M. H. Chen, C. T. Yeh, C. M. Chu, A. N. Lin, F. H. Chiou, T. H. Chang, and Y. F. Liaw. 1996. Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes. J. Clin. Investig. 97:577-584.
44. Tynan, F. E., D. Elhassen, A. W. Purcell, J. M. Burrows, N. A. Borg, J. J. Miles, N. A. Williamson, K. J. Green, J. Tellam, L. Kjer-Nielsen, J. McCluskey, J. Rossjohn, and S. R. Burrows. 2005. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J. Exp. Med. 202:1249-1260.
45. + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J. Virol. 78:5707-5719.
46. Wentworth, P. A., A. Sette, E. Celis, J. Sidney, S. Southwood, C. Crimi, S. Stitely, E. Keogh, N. C. Wong, B. Livingston, D. Alazard, A. Vitiello, H. M. Grey, F. V. Chisari, R. W. Chesnut, and J. Fikes. 1996. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int. Immunol. 8:651-659.
47. Yewdell, J. W. 2006. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25:533-543.